Product NDC: | 65977-5042 |
Proprietary Name: | Indomethacin |
Non Proprietary Name: | Indomethacin |
Active Ingredient(s): | 25 mg/1 & nbsp; Indomethacin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65977-5042 |
Labeler Name: | Hetero Drugs Ltd., |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091240 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110412 |
Package NDC: | 65977-5042-1 |
Package Description: | 100 CAPSULE in 1 BOTTLE (65977-5042-1) |
NDC Code | 65977-5042-1 |
Proprietary Name | Indomethacin |
Package Description | 100 CAPSULE in 1 BOTTLE (65977-5042-1) |
Product NDC | 65977-5042 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Indomethacin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110412 |
Marketing Category Name | ANDA |
Labeler Name | Hetero Drugs Ltd., |
Substance Name | INDOMETHACIN |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |